The WHO confirmed on 13 March 2026 that 99 countries and territories received batches of infant formula subject to recall, up from the 60 countries widely reported earlier. 144 suspected and confirmed cases were identified between 1 January and 25 February 2026 across 10 countries, with Belgium the only country to have lab-confirmed any cases so far.
The real case count is almost certainly higher. The Netherlands alone has received 221 reports from parents, and Denmark another 32, but these do not meet the INFOSAN case definition because most countries do not have laboratory capacity to test for cereulide. WHO has classified the overall public health risk as moderate. Brands not affected by the recall include Holle, Kendamil (US version), Jovie and Pure Goat.
If you have been following the cereulide contamination story since it broke in December 2025, the picture has been moving faster than most news coverage can keep up with. The WHO's 13 March update is the first consolidated official account of the full scope, and it answers several questions that had been open for weeks.
For the full backstory of how this started, see our coverage of the 2026 formula shortage. This piece is about what has changed since then, and specifically what the WHO is now saying that previous reporting either missed or understated.
What the WHO actually confirmed
On 13 March 2026, the WHO published a Disease Outbreak News update consolidating information reported by member states through the International Food Safety Authorities Network, known as INFOSAN. The key figures:
99 countries and territories received batches of infant formula products subject to recall, across all six WHO regions. Earlier news coverage had variously reported 40, 60, and 80 countries. The 99 figure is the current official count as of 25 February 2026.
144 suspected and confirmed cases were reported across ten countries between 1 January and 25 February 2026. Under the INFOSAN case definition, these are infants with symptoms of cereulide intoxication who consumed recalled product. The country breakdown is: United Kingdom 61, Spain 41, France 11, Austria 9, Belgium 8 confirmed, Brazil 5, Czechia 4, Singapore 3, Italy 1, and Hong Kong SAR 1.
Belgium is the only country to have laboratory-confirmed any cases. All eight Belgian cases were infants who consumed the recalled product and tested positive in clinical samples. Every other case in WHO's count is a suspected case based on symptoms and exposure history, without lab confirmation.
A much larger pool of self-reported cases exists but falls outside the WHO's formal count. The Netherlands reported 221 cases from parents through the Dutch Food and Consumer Product Safety Authority, and Denmark 32. WHO notes that these numbers are not directly comparable with the INFOSAN definition because they are self-reported rather than clinically characterised. But the ratio is significant. The formal count is 144 across ten countries. The Netherlands alone, outside the formal count, has more parent reports than that.
The testing gap nobody talks about
This is the part of the WHO update that deserves more attention than it is getting. The reason only Belgium has confirmed cases is not that only Belgian infants were exposed. It is that only Belgium has been able to test for the toxin.
Cereulide is not a routine laboratory assay. Most clinical microbiology labs, including those in countries with strong public health infrastructure, do not have validated testing protocols for it in human samples. WHO states this plainly: "Since this is not a routinely tested contaminant or condition, diagnostic challenges and limited surveillance capacity are hindering Member States' ability to identify confirmed cases."
This has two practical implications worth naming. First, the case count in the WHO report almost certainly undercounts actual illness, possibly by a large margin. Mild presentations resemble common childhood viral gastroenteritis, and without a test, they are not distinguishable. Second, the implication of "limited laboratory capacity" extends in the other direction too. For a parent whose baby became unwell after consuming a recalled product, there is usually no test available to confirm or rule out cereulide exposure as the cause.
WHO's update includes a detail that has not featured prominently in news coverage: "For babies who rely entirely on formula, repeated feedings can increase the amount of toxin consumed, and using contaminated formula for rehydration can worsen illness." The toxin has a very low symptomatic dose threshold and remains fully active under gastric conditions. This is different from a one-off foodborne exposure. An infant feeding six to eight times a day from a contaminated can is receiving cumulative exposure, and standard dehydration management using the same formula makes the problem worse, not better.
Why is the formula recall still expanding?
One detail in the WHO update has barely been mentioned in consumer coverage: more than three months after the contamination was first identified, the Chinese ARA oil producer at the centre of this has still not provided complete traceability information to WHO.
The sequence, according to the WHO and the ECDC outbreak assessment: In January 2026, the European Commission requested that INFOSAN contact Chinese authorities for information about the contaminated batches of ARA oil, their distribution, the root cause analysis, and remedial action taken. As of 13 February 2026, this information had not been provided. The 13 March WHO update repeats the same point. The complete traceability from the original implicated manufacturer has not been supplied.
In the absence of that information, what is known is that an analysis of 65 ARA oil batches received from the Chinese producer between April 2023 and October 2025 revealed contamination dating back to October 2024, with the highest concentration in deliveries made in July 2025. Contaminated oil was distributed to manufacturers in South Africa, Argentina, Brazil, Germany, Spain, France, India, the Netherlands, the Philippines and Switzerland, among others. Secondary distribution through commercial supply chains has complicated efforts to identify all affected products. WHO notes that further recalls remain possible if additional affected batches or product categories are identified.
Baby formula recall 2026: what to do if yours is affected
The recommendations section of the WHO update is aimed at member states, not directly at consumers, but several points translate cleanly into practical guidance for parents.
WHO recommends promoting safe alternative nutrition options where affected products have been withdrawn. This is significant. WHO is not telling parents to wait for recalled brands to come back. It is actively recommending switching. The phrasing includes the line "promote breastfeeding and address barriers to accessing safe alternative nutrition." For formula-dependent families, the alternative nutrition language means formula brands unaffected by this recall.
Verify recall effectiveness, including online sales. WHO specifically flags that recalled product has been found on retail shelves in multiple countries, and that online sales in particular are harder to police. Parents should check batch codes on any product purchased through third-party online sellers, and should not trust the absence of a news story as confirmation of safety for an imported product.
Early presentation to health facilities for infants with sudden vomiting. WHO singles out sudden vomiting as the red flag symptom and emphasises supportive care, because no specific antidote or targeted therapy exists. Onset is typically within 30 minutes to six hours of exposure.
Do not attempt to rehydrate with the same formula. This is the critical warning. If an infant consuming formula becomes acutely unwell with vomiting, the instinct to offer more formula or reconstitute differently to manage dehydration will make it worse if the formula is contaminated. Use oral rehydration solution and get medical care.
Sudden onset vomiting within 30 minutes to six hours of a feed. Nausea, abdominal pain, signs of dehydration such as reduced wet nappies or lethargy. Infants under six months are more vulnerable to rapid dehydration and electrolyte imbalance from cereulide exposure than older children.
If any of these symptoms appear after feeding with a product that is on a recall list, or a product you are unsure about, stop using it, contact your paediatrician or emergency services, and bring the can or package if possible.
What infant formula is not on recall?
The cereulide recall has affected specific brands using contaminated ARA oil from one Chinese supplier. It has not affected every formula on the market. Based on public statements from manufacturers, regulatory confirmations, and ingredient sourcing disclosures, the following brands were not part of the cereulide recall.
| Brand | Cereulide recall | Notes |
|---|---|---|
| Holle (cow and goat) | Not affected | Demeter biodynamic. Different supply chain for fatty acids. |
| Kendamil (US version) | Not affected | The Canadian CFIA recalled a specific Costco Canada lot; US FDA has not issued a recall for Kendamil sold in the US. |
| Jovie | Not affected | Dutch goat-milk formula. Not involved in cereulide recall. |
| Pure Goat | Not affected | UK manufactured. Not involved in cereulide recall. |
| HiPP Combiotik | Not affected | HiPP was not named in the cereulide recall. Verify batch codes if importing. |
| Nestle SMA, Beba, Guigoz, NAN | Affected | Multiple products recalled across 60+ countries. |
| Danone Aptamil, Cow and Gate, Nutrilon | Affected | Specific batches recalled. Check manufacturer lists. |
| Lactalis Picot | Affected | Six lots across 18 countries recalled. |
For a full brand-by-brand availability table including the separate ByHeart botulism recall in the US, see our main formula shortage coverage.
What this means if you import European formula
A meaningful number of US parents import European formula through third-party retailers and online sellers. The WHO's 99-country scope means the cereulide recall is directly relevant to you, even though the major affected brands (SMA, Aptamil, NAN, Cow and Gate) are not sold through US retail channels.
If you import formula, three practical points matter. First, you are operating outside the FDA's recall notification system. The FDA does not recall products it does not regulate. Second, the European Rapid Alert System for Food and Feed (RASFF) is the official EU recall database, and individual national food safety authorities publish recall notices in their own languages. Third, online and third-party importers are not required to proactively notify you of a recall on a product you purchased from them. You have to check yourself.
The WHO specifically flagged online sales as a gap in recall enforcement. Recalled product has been found for sale online weeks and even months after the recall was announced. If you are ordering from a specialist importer, check the batch codes on the cans you receive against the manufacturer's published recall list, and do not assume the seller has filtered out recalled stock.
Is the baby formula recall over?
Three things are worth watching over the coming weeks.
Further recalls are possible. WHO explicitly notes that the scope may continue to expand if additional affected batches are identified. Secondary distribution through commercial supply chains means contaminated ARA oil may have reached products beyond the ones currently named. The European Commission has placed new restrictions on Chinese ARA oil imports requiring test certificates, which will prevent future contamination but does not close the loop on what was distributed before December 2025.
EFSA has set the first regulatory threshold for cereulide in infant formula. On 2 February 2026, the European Food Safety Authority published an acute reference dose for cereulide in infants: 0.014 micrograms per kilogram bodyweight. Before this, no generally accepted regulatory limit existed. The absence of that limit is part of why contamination went undetected in supplier testing for months.
The Chinese supplier has not yet provided traceability information. Until that information is shared through INFOSAN, the full distribution map of contaminated ARA oil cannot be finalised. Regulators, manufacturers, and parents are all operating with incomplete information about where the contaminated product went.
The most important thing the WHO's 13 March update makes clear is how much is still unknown, nearly four months after the first recall.
Ninety-nine countries received contaminated product, one country has been able to test for the toxin, and the supplier at the origin of all of it has still not provided root cause information. The 144 confirmed and suspected cases in the WHO count are almost certainly a floor, not a ceiling. The Netherlands alone has 221 parent reports sitting outside that count because the definition requires laboratory confirmation that the infrastructure does not exist to perform.
This is not a reason to panic. In most affected countries, recalls have reduced exposure to low levels. Parents whose formula was not on a recall list and whose baby is well have very little to be concerned about. But it is a reason to think carefully about the systems that got us here. A toxin that does not have a standardised regulatory threshold, that most labs cannot test for, that a single global supplier can inadvertently distribute to 99 countries, and whose extent we still cannot measure accurately. That is the story. The specific case count, whatever it turns out to be, is downstream of it.
If you are still feeding a recalled brand, switch. WHO is explicitly recommending switching and naming it as part of its guidance to member states. The brands that were not affected are available and have been throughout. That is the practical answer. The systemic answer takes longer.